{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicqku5amkj7yzolygwk5ijfqq6squztdaj5ozcbrh2drsfw3y4b2a",
    "uri": "at://did:plc:amgpmo7quvdl4rzvmmjibtx6/app.bsky.feed.post/3mo4j3i6aana2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifmu5cpguvldconwxbef3zpyibxy3urtho2lca4w7q3r4m5u2tri4"
    },
    "mimeType": "image/jpeg",
    "size": 500352
  },
  "path": "/2026/06/12/health/ebola-treatment-bundibugyo-virus.html",
  "publishedAt": "2026-06-12T17:47:18.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Ebola Virus",
    "Clinical Trials",
    "Research",
    "Drugs (Pharmaceuticals)",
    "Medicine and Health",
    "World Health Organization",
    "Regeneron Pharmaceuticals Inc",
    "Congo, Democratic Republic of (Congo-Kinshasa)",
    "East Africa",
    "Uganda",
    "your-feed-science"
  ],
  "textContent": "Trials are beginning on several drugs that have shown promise in preliminary studies against the virus that is causing the current outbreak.",
  "title": "Scientists Race to Test Treatments as Ebola Outbreak Widens"
}